PCN134 - Cost-Utility Analysis of Practice Deviations From Guidelines in HER2-Targeted Testing and Treatment for Breast Cancer

Autor: Ferrusi, I.L., Kulin, N.A., Goeree, R., Leighl, N., Pullenayegum, E.M., Phillips, K., Marshall, D.
Zdroj: In Value in Health May 2014 17(3):A91-A91
Databáze: ScienceDirect